Related Experiment Video
Updated: Mar 19, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Defensive efficacy interim design: Dynamic benefit/risk ratio view using probability of success
1a Department of Biostatistics and Data Management , Novartis Oncology , East Hanover , New Jersey , USA.
Abstract:
Traditional efficacy interim design is based on alpha spending which does not have intuitive interpretation and hence is difficult to communicate with non-statistician colleagues. The alpha-spending approach is based on efficacy alone and hence does not have the flexibility to incorporate newly emerged safety signal. Newly emerged safety signal may nullify the originally set efficacy boundary. In contrast, the probability of success (POS) concept has intuitive interpretation and hence can facilitate our communication with non-statistician colleagues and help to obtain health authority (HA) buying. The success criteria of POS are not restricted to statistical significance. Hence, POS has the capability to incorporate both efficacy and safety information. We propose to use POS and its credible interval to design efficacy interim. In the proposed method, the efficacy boundary is adjustable to offset newly emerged safety signal.
Related Concept Videos
Probability Laws
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Relative Risk
Hazard Rate
Hazard Ratio
For example, in a clinical trial...
Odds Ratio

